NG_008898.2:g.15748C>T NC_000019.10:g.46756793C>T NC_000019.9:g.47260050C>T NP_077277.1:p.Pro448Leu
Q9H9S5:p.Pro448Leu NM_001039885.3:c.1343C>T NM_024301.5:c.1343C>T NP_001034974.1:p.Pro448Leu LRG_761:g.15748C>T LRG_761t1:c.1343C>T LRG_761p1:p.Pro448Leu More...
|
05/01/2023 |
missense|missense variant |
pathogenic|likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2I; Cerebroocular dysgenesis; Cerebroocular dysplasia muscular dystrophy syndrome; Chemke syndrome; COD-MD syndrome; Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies type A5; Hard +/- E syndrome; Hydrocephalus, agyria and retinal dysplasia; Limb-girdle muscular dystrophy-dystroglycanopathy, type C5; MUSCULAR DYSTROPHY, CONGENITAL, 1C; MUSCULAR DYSTROPHY, CONGENITAL, FKRP-RELATED; MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2I; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1; MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5; MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT), TYPE B, 5; MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 5; Muscular dystrophy-dystroglycanopathy type B5; MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY, LIMB-GIRDLE, FRKP-RELATED; Muscular dystrophy-dystroglycanopathy, type A; none provided; Pagon syndrome; Walker-Warburg syndrome; WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, FKRP-RELATED; WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, POMT1-RELATED; Warburg syndrome |